The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patientsprotocol for a double-blind, placebo-controlled randomized trial

Omara Dogar, Deepa Barua, Melanie Boeckmann, Helen Elsey, Razia Fatima, Rhian Gabe, Rumana Huque, Ada Keding, Amina Khan, Daniel Kotz, Eva Kralikova, James N. Newell, Iveta Nohavova, Steve Parrott, Anne Readshaw, Lottie Renwick, Aziz Sheikh, Kamran Siddiqi, TB Tobacco Project Consortium

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1716-1726
Number of pages11
JournalAddiction
Volume113
Issue number9
DOIs
Publication statusPublished - 1 Sep 2018

Keywords

  • Bangladesh
  • cytisine
  • low- and-middle income countries
  • Pakistan
  • placebo-controlled randomized trial
  • smoking cessation
  • tobacco cessation
  • tuberculosis
  • PULMONARY TUBERCULOSIS
  • TOBACCO-SMOKE
  • CESSATION
  • METAANALYSIS
  • SYMPTOMS
  • NICOTINE
  • WITHDRAWAL
  • COMPONENTS
  • PAKISTAN
  • CRITERIA

Cite this

Dogar, O., Barua, D., Boeckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., Keding, A., Khan, A., Kotz, D., Kralikova, E., Newell, J. N., Nohavova, I., Parrott, S., Readshaw, A., Renwick, L., Sheikh, A., Siddiqi, K., & TB Tobacco Project Consortium (2018). The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patientsprotocol for a double-blind, placebo-controlled randomized trial. Addiction, 113(9), 1716-1726. https://doi.org/10.1111/add.14242